Curate Biosciences
PrivateLast Round
Debt
Oct 5, 2022
Total Funding Raised
$53.1M
Company Overview
Curate Biosciences operates in Healthcare & Life Sciences and is based in Carlsbad, California. Its latest recorded funding round was a Debt round in October 2022.
Curate Biosciences is a biotechnology company that develops microfluidic-based cell processing systems to improve the quality and manufacturing efficiency of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curate Biosciences Comparables
Compare Curate Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Applied Cells | 86% | |
| Limula | 84% | |
| NanoCellect Biomedical | 83% |
For institutional investors. Book with your work email.
Curate Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 5, 2022 | ||||
| Series C | Apr 2, 2020 | ||||
| Grant | Jun 3, 2019 | ||||
| Series A | Oct 1, 2015 | ||||
| Angel | Mar 1, 2014 |
For institutional investors. Book with your work email.
Curate Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bio, Tech and Beyond | Series A |
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Vensana Capital | Series C |
| Amgen Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2022
$10M debt round completed.
- Apr 2, 2020
$34M round led by Vensana Capital.
For institutional investors. Book with your work email.
Curate Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Curate Biosciences's valuation, stock price, and market status.
Is Curate Biosciences a public or private company?
Curate Biosciences is a private company.
What is the current stock price of Curate Biosciences?
Curate Biosciences is a private company, so its shares have no public market price. Caplight tracks Curate Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curate Biosciences worth (valuation)?
Valuation information for Curate Biosciences is not publicly available.
Can I buy Curate Biosciences stock?
Curate Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curate Biosciences's last funding round?
Curate Biosciences's most recent funding round was Debt on October 5, 2022.
Who are the main investors in Curate Biosciences?
Key investors in Curate Biosciences include National Cancer Institute, Vensana Capital.
Will Curate Biosciences IPO soon?
No public IPO plans have been announced for Curate Biosciences.
How can I track Curate Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Curate Biosciences's shares on secondary markets.